• Epoxomicin Proteasome Inhibitor Workflow

  2026-08-22

  Epoxomicin provides a selective, irreversible way to interrogate proteasome-dependent protein turnover during ER stress and proteostasis failure. This practical guide connects dose design, degradation assays, UBR1/UBR2 biology, and troubleshooting for more reproducible ubiquitin-proteasome pathway research.

• Phytol Workflows for RXR Signaling Assays

  2026-08-21

  Build more reliable Phytol experiments by separating solvent, dose, isomer, and time effects across orthogonal readouts. This practical workflow connects RXR reporter assays with GABAergic and PPARα-focused studies while using the reference polymer study as a model for disciplined experimental design.

• YTHDF1–THBS1 Control of Osteogenesis under Hypoxia

  2026-08-20

  Shi and colleagues identify a compensatory YTHDF1–THBS1 pathway that supports osteogenic differentiation of MC3T3-E1 cells during hypoxia. Their experiments connect m6A-dependent RNA regulation with osteogenic markers, alkaline phosphatase activity, mineralization, and THBS1 transcript stability, providing a mechanistic framework for hypoxia-associated bone loss in peri-implantitis.

• PPACK Dihydrochloride for Thrombin Assays

  2026-08-20

  PPACK Dihydrochloride provides a high-affinity, irreversible way to remove thrombin activity from platelet and coagulation experiments without directly antagonizing platelet P2 receptors. This guide translates that distinction into practical assay workflows, controls, optimization steps, and troubleshooting strategies for blood coagulation research.

• Dabigatran in Thromboembolism: Evidence and AF Practice

  2026-08-19

  The 2015 review by Enriquez and colleagues synthesizes the pharmacology, clinical trial evidence, pharmacokinetics, and safety considerations surrounding dabigatran, the first widely introduced non-vitamin K oral anticoagulant. Its main practical contribution is to show how direct thrombin inhibition can provide effective thromboembolism prevention with predictable dosing, while also emphasizing renal clearance, drug interactions, and bleeding management.

• Carbapenemase Transmission in CREC, Guangdong

  2026-08-19

  Chen et al. characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates collected from eight teaching hospitals in Guangdong during 2022–2024. The study links predominantly plasmid-associated blaNDM-1 with multidrug resistance, high conjugative transfer potential, and genetically related hospital isolates, while also defining important limits for interpreting local transmission data.

• PPACK Dihydrochloride as a Thrombin Timing Gate

  2026-08-18

  PPACK Dihydrochloride is more than an irreversible thrombin inhibitor: it can function as a temporal control for separating thrombin-dependent coagulation from platelet P2-receptor signaling. This article develops an assay-design framework grounded in the NF449 platelet study and practical experimental interpretation.

• Sulfo-Cy5 NHS Ester for Immune-Cell Imaging

  2026-08-17

  Sulfo-Cy5 NHS ester enables aqueous protein conjugation and high-contrast cellular imaging without routine organic co-solvents. This guide connects its labeling chemistry to assay design for VLA-4 localization and immune-microenvironment studies.

• Azilsartan medoxomil monopotassium: Lab Guide

  2026-08-17

  This scenario-driven guide explains how Azilsartan medoxomil monopotassium, SKU B1071, can improve the interpretability of cell viability, proliferation, and cytotoxicity workflows involving AT1 receptor biology. It connects receptor-binding evidence with practical formulation, dosing, solvent, storage, and vendor-selection decisions.

• Meropenem trihydrate in Resistance Research

  2026-08-16

  Build reproducible workflows for susceptibility testing, resistance phenotyping, and LC-MS/MS metabolomics with a broad-spectrum carbapenem antibiotic. Practical guidance connects meropenem exposure design with CPE biomarker discovery, while keeping formulation, stability, and translational limitations visible.

• Prochlorperazine in Melanoma Research Workflows

  2026-08-15

  Prochlorperazine combines dopamine D2 receptor antagonism with experimentally useful effects on melanoma viability, motility, MITF, and tyrosinase. This workflow-oriented guide shows how to build reproducible concentration-response, wound-healing, and protein-expression assays while avoiding solvent, formulation, and interpretation errors.

• Imatinib (STI571) for Reliable Kinase Assays

  2026-08-14

  A scenario-based guide to using Imatinib (STI571), SKU B2171, in cell viability, proliferation, cytotoxicity, and kinase-signaling workflows. It connects target potency, formulation, controls, protocol parameters, and CML-related interpretation to improve experimental consistency without overstating what a viability endpoint can prove.

• PDGF-BB: Murine Recombinant Protein for Vascular Assays

  2026-08-14

  Use murine recombinant PDGF-BB as a defined mitogenic comparator for smooth muscle and connective-tissue cell models, then layer it with hypoxia or metabolic stress to dissect vascular remodeling. This workflow connects receptor-driven proliferation with the lactate–ALDOB–DRP1 biology highlighted in pulmonary hypertension research.

• Silk Fibroin–Ce6 Films for Infected Wound Healing

  2026-08-13

  The reference study developed an aligned silk fibroin electrospun film conjugated with Chlorin e6 (Ce6) for light-activated treatment of Staphylococcus aureus-infected wounds. Its significance lies in combining directional cell guidance, reactive oxygen species generation, antibacterial photodynamic therapy, and later-stage macrophage modulation within one biomaterial platform.

• Oxaliplatin: From DNA Damage to Translation

  2026-08-13

  Oxaliplatin is more than a cytotoxic reagent: it is a mechanistic probe for DNA damage, apoptosis, treatment resistance, and biomarker-guided translation. This thought-leadership guide connects its platinum-DNA adduct activity with SMC2 and SMC4 findings in breast cancer, practical validation strategies, and more predictive cancer chemotherapy research.

8546 records 1/570 page Next 12345 下5页 Last page